FindTrial
Sign In

Bevacizumab-800CW

DRUG5 trials

Sponsors

University Medical Center Groningen

Conditions

Barrett EsophagusBreast CancerColon CarcinomaEndometriosisGastrointestinal DysplasiaInverted PapillomaMolecular Fluorescence ImagingPancreatic Adenocarcinoma

Phase 1

Fluorescence Guided Surgery in Breast Cancer
CompletedNCT02583568
University Medical Center GroningenBreast Cancer
Start: 2015-10-31End: 2017-02-28Updated: 2017-02-13
Near-infrared Image Guided Surgery in Pancreatic Adenocarcinoma
TerminatedNCT02743975
University Medical Center GroningenPancreatic Adenocarcinoma, Pancreatic Cancer
Start: 2016-12-01End: 2018-05-01Updated: 2020-01-28
Feasibility Study of Using Molecular Fluorescence Guided Surgery in Endometriosis
NCT02975219
University Medical Center GroningenEndometriosis
Start: 2017-05-01End: 2019-01-31Target: 10Updated: 2017-06-27
Image Guided Surgery in Sinonasal Inverted Papilloma
NCT03925285
University Medical Center GroningenInverted Papilloma, Molecular Fluorescence Imaging
Start: 2019-05-06End: 2022-01-01Updated: 2021-05-03

Unknown Phase

Safety and Feasibility of Immuno-OCT
Not yet recruitingNCT06008522
University Medical Center GroningenBarrett Esophagus, Colon Carcinoma, Gastrointestinal Dysplasia
Start: 2024-04-01End: 2025-03-01Target: 15Updated: 2024-03-20

Related Papers

Fluorescence grid analysis for the evaluation of piecemeal surgery in sinonasal inverted papilloma: a proof-of-concept study
European Journal of Nuclear Medicine and Molecular Imaging2021-11-057 citations
Detection by fluorescence of pituitary neuroendocrine tumour (PitNET) tissue during endoscopic transsphenoidal surgery using bevacizumab-800CW (DEPARTURE trial): study protocol for a non-randomised, non-blinded, single centre, feasibility and dose-finding trial
BMJ Open2021-10-019 citations